Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding

被引:0
|
作者
An-Ping Su [1 ]
Zhao-Da Zhang [2 ]
Bo-Le Tian [2 ]
Jing-Qiang Zhu [1 ]
机构
[1] Department of Thyroid Surgery West China Hospital, Sichuan University
[2] Department of Hepatobiliopancreatic Surgery West China Hospital, Sichuan University
关键词
liver cirrhosis; portal hypertension; recurrent variceal bleeding; transjugular intrahepatic portosystemic shunt; open splenectomy and esophagogastric devascularization;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Transjugular intrahepatic portosystemic shunt(TIPS) and open splenectomy and esophagogastric devascularization(OSED) are widely used to treat patients with portal hypertension and recurrent variceal bleeding(PHRVB). This study aimed to compare the effectiveness between TIPS and OSED for the treatment of PHRVB.METHODS: The data were retrospectively retrieved from 479 cirrhotic patients(Child-Pugh A or B class) with PHRVB, who had undergone TIPS(TIPS group) or OSED(OSED group) between January 1, 2010 and October 31, 2014.RESULTS: A total of 196 patients received TIPS, whereas 283 underwent OSED. Within one month after TIPS and OSED, the rebleeding rates were 6.1% and 3.2%, respectively(P=0.122). Significantly lower incidence of pleural effusion,splenic vein thrombosis, and pulmonary infection, as well as higher hepatic encephalopathy rate, shorter postoperative length of hospital stay, and higher hospital costs were observed in the TIPS group than those in the OSED group. During the follow-up periods(29 months), significantly higher incidences of rebleeding(15.3% vs 4.6%, P=0.001) and hepatic encephalopathy(17.3% vs 3.9%, P=0.001) were observed in the TIPS group than in the OSED group. The incidence of instent stenosis was 18.9%. The survival rates were 91.3% in the TIPS group and 95.1% in the OSED group. The long-term liver function did not worsen after either TIPS or OSED.CONCLUSION: For the patients with liver function in the Child-Pugh A or B class, TIPS is not superior over OSED in terms of PHRVB treatment and rebleeding prevention.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [21] Transjugular intrahepatic portosystemic shunt for treatment of bleeding ectopic varices with portal hypertension
    Shibata, D
    Brophy, DP
    Gordon, FD
    Anastopoulos, HT
    Sentovich, SM
    Bleday, R
    DISEASES OF THE COLON & RECTUM, 1999, 42 (12) : 1581 - 1585
  • [22] RECURRENT URINARY CONDUIT BLEEDING IN A PATIENT WITH PORTAL-HYPERTENSION - MANAGEMENT WITH A TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT
    ZIMMERMAN, G
    SMITH, DC
    TAYLOR, FC
    HADLEY, HR
    UROLOGY, 1994, 43 (05) : 748 - 751
  • [23] Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension
    Barange, K
    Rousseau, H
    Vinel, JP
    PRESSE MEDICALE, 1997, 26 (24): : 1162 - 1167
  • [24] The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension
    Hassoun, Z
    Pomier-Layrargues, G
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (01) : 1 - 4
  • [25] SHUNT PATENCY, RECURRENT BLEEDING AND SURVIVAL AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) FOR VARICEAL HEMORRHAGE
    SAHAGUN, G
    BENNER, KG
    BARTON, RE
    KELLER, FS
    ROSCH, J
    HEPATOLOGY, 1992, 16 (04) : A246 - A246
  • [26] Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding
    Xiao-Yan Sun
    Guang-Chuan Wang
    Jing Wang
    Guang-Jun Huang
    Chun-Qing Zhang
    Hepatobiliary&PancreaticDiseasesInternational, 2021, 20 (02) : 128 - 136
  • [27] Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding
    Sun, Xiao-Yan
    Wang, Guang-Chuan
    Wang, Jing
    Huang, Guang-Jun
    Zhang, Chun-Qing
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (02) : 128 - 136
  • [28] Oxaliplatin-Induced Hepatoportal Sclerosis, Portal Hypertension, and Variceal Bleeding Successfully Treated With Transjugular Intrahepatic Portosystemic Shunt
    Lawal, Taoreed O.
    Farris, Alton B.
    El-Rayes, Bassel F.
    Subramanian, Ram M.
    Kim, Hyun S.
    CLINICAL COLORECTAL CANCER, 2012, 11 (03) : 224 - 227
  • [29] Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
    Huang Long
    Yu Qing-Sheng
    Zhang Qi
    Liu Ju-Da
    Wang Zhen
    中华医学杂志英文版, 2015, 128 (06) : 826 - 834
  • [30] Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
    Huang, Long
    Yu, Qing-Sheng
    Zhang, Qi
    Liu, Ju-Da
    Wang, Zhen
    CHINESE MEDICAL JOURNAL, 2015, 128 (06) : 826 - 834